TABLE II.

VALUES FOR MAYO MODEL VARIABLES IN 216 PRIMARY SCLEROSING CHOLANGITIS LIVER RECIPIENTS STRATIFIED ACCORDING TO THE CENTER OF TRANSPLANTATION

Variable		University of Pittsburgh, n=158	Mayo Medical Center, n=58	p Value
Age, yrs.* . . . . . .		41.6±11.7	43.5±10.0	0.2
Bilirubin, mgm./dl.*		14.1±13.4	11.2±11.5	0.06
Splenomegaly . . . .		116 (73.4)	21 (36.2)	<0.001
Histologic stage* . .		3.7±0.6	3.9 ±0.2	0.002
	1 and 2 . . . . . .	7 (4.4)	0 (0)
	3 . . . . . . . . . .	30 (19)	3 (5.2)
	4 . . . . . . . . . .	121 (76.6)	55 (94.8)
Risk score* . . . . .		5.1±0.9	4.9±0.9	0.2

^*Mean±S.D.

Numbers in parentheses are percentages.